Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06396039 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis

StatusActive, Not Recruiting
PhasePhase 4
Started2024-05-15
View on ClinicalTrials.gov ↗

Amendment history

2025-04-15
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v7
Trial statusRecruiting→Active, Not Recruiting
Study sites25 entries, revised
BeijingLocal Tiantan Hospital, Capital Medical University The First Affiliated Hospital, Sun Yat-sen University The Second Affiliated Hospital of Guangzhou Medical University Peking University Shenzhen Hospital The Second Hospital of Hebei Medical University The Second Affiliated Hospital of Harbin Medical Unive [...] Institution - Sichuan0002 Local UniversityInstitution - 0012 TheLocal FirstInstitution People's- Hospital0022 Local ofInstitution Yunnan- Province0008 SirLocal RunInstitution Run- Shaw0004 Local HospitalInstitution Zhejiang- University0006 Local SchoolInstitution of- Medicine0018 TheLoc [...] [...]
2024-09-18
Study Status, Contacts/Locations v6
Study sites25 entries, revised
LocalThe InstitutionSecond -Affiliated 0006Hospital of Harbin Medical University LocalRuijin InstitutionHospital, -Shanghai 0016Jiaotong University School of Medicine LocalSir InstitutionRun -Run 0019Shaw Hospital Zhejiang University School of Medicine LocalFujian InstitutionMedical -University 0025Union Hospital LocalShengjing InstitutionHospital -Of 0021China Medical University
2024-08-19
Study Status, Contacts/Locations v5
Study sites25 entries, revised
LocalThe InstitutionFirst Affiliated Hospital, Sun Yat-sen 0012University LocalPeking InstitutionUniversity -Shenzhen 0008Hospital
2024-08-01
Study Status, Contacts/Locations v4
Study sites25 entries, revised
LocalThe InstitutionFirst -Affiliated 0018Hospital of Zhengzhou University LocalThe InstitutionFirst -Hospital 0005of Jilin University LocalThe InstitutionFirst -Affiliated 0023Hospital of Xinjiang Medical University LocalThe InstitutionFirst -People's 0024Hospital of Yunnan Province
2024-07-16
Study Status, Contacts/Locations v3
Study sites25 entries, revised
LocalBeijing InstitutionTiantan Hospital, Capital Medical University The Second Affiliated Hospital of Guangzhou Medical University Tongji Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology First Hospital of Shanxi Medical University West China Hospital - 0002Sichuan University LocalPeking InstitutionUniversity -First 0022Hospital LocalThe InstitutionAffiliated -Hospital 0007of Guizhou Medical University LocalInner InstitutionMongolia -People's 0015 Local Institution - 0011 Local Institution - 0009 Local Institution - 0010 Local Institution - 0013Hospit [...]
Show 2 earlier versions
2024-06-28
Study Status, Contacts/Locations v2
Study sites25 entries, revised
LocalThe InstitutionFirst -Affiliated 0003Hospital of NanChang University LocalThe InstitutionFirst -Affiliated 0020Hospital of Wenzhou Medical University LocalXianyang InstitutionHospital -of 0017Yan'an University
2024-06-05
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations, References v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-05-10→confirmed 2024-05-15
Study sites3→25
2024-04-29
Original filing
The purpose of this study is to assess the effectiveness and safety of ozanimod in Chinese adults with relapsing multiple sclerosis.
Trial Details
NCT Number NCT06396039
Lead Sponsor Bristol-Myers Squibb
Conditions Relapsing Multiple Sclerosis
Enrollment 84 participants
Start Date 2024-05-15
Primary Completion 2028-12-29 (estimated)
Study Completion 2029-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-16